Search


	Podcast:		Cell & Gene: The Podcast
	Episode:		Improving TCR T-Cell Persistence and Efficacy with Adaptimmune's Dennis Williams
	Category:		Science & Medicine
	Duration:		00:20:52
	Publish Date:		2024-11-07 09:00:00
	Description:		We love to hear from our listeners. Send us a message. On this episode of Cell & Gene: The Podcast, Host Erin Harris talks to Dennis Williams, Senior Vice President of Late Stage Development at Adaptimmune. Williams shares valuable insights into the groundbreaking world of TCR T-cell therapies, with a particular focus on the TECELRA trial. The trial led to the FDA approval of Tecelra, marking a significant milestone as the first engineered T-cell therapy for solid tumors. Williams delves into the complexities of developing this innovative treatment for synovial sarcoma, a rare and aggressive form of soft-tissue cancer. He also highlights the unique challenges and promising outcomes associated with TCR T-cell therapies, offering a comprehensive understanding of this cutting-edge approach in cancer immunotherapy. Subscribe to the podcast! Apple \| Spotify \| YouTube
	Total Play:		0